Cochrane Methods Group

Cochrane Methods Group
Name	Cochrane Methods Group
Formation	1990s
Type	Research methods network
Headquarters	Global (distributed)
Leader title	Convenor

Cochrane Methods Group is a specialist network within an international evidence-synthesis community that focuses on developing, evaluating, and promoting methodological standards for systematic reviews and meta-analyses. It engages with a wide range of stakeholders including clinicians, statisticians, policymakers, and patient advocates to improve the reliability of health evidence used by organizations and agencies. Its work intersects with major public health institutions, academic centers, guideline developers, and funding bodies across numerous countries.

History and formation

The group traces roots to methodological initiatives in the 1990s that involved contributors from World Health Organization, National Institutes of Health, Medical Research Council (United Kingdom), Agency for Healthcare Research and Quality, and academic centers such as Johns Hopkins University, University of Oxford, McMaster University, Harvard University, and University of Toronto. Early formative meetings included participation from figures associated with Cochrane Collaboration, British Medical Journal, The Lancet, New England Journal of Medicine, and conferences like International Congress on Peer Review and Scientific Publication and Evidence Live. Funders and policy partners present in formation dialogues included Wellcome Trust, National Health Service (England), European Commission, Canadian Institutes of Health Research, Australian National Health and Medical Research Council, and Bill & Melinda Gates Foundation. Key methodological debates paralleled work by groups linked to Campbell Collaboration, PRISMA Statement, GRADE Working Group, and networks formed after symposia at Royal Society, Academy of Medical Sciences (United Kingdom), and Institute of Medicine (United States).

Scope and objectives

Mandates encompass development of standards relevant to systematic review processes used by bodies such as World Bank, Organisation for Economic Co-operation and Development, United Nations, and national health technology assessment agencies like National Institute for Health and Care Excellence, Agency for Healthcare Research and Quality, and Canadian Agency for Drugs and Technologies in Health. Objectives include producing guidance that aligns with reporting frameworks like PRISMA Statement and quality-assessment systems such as GRADE Working Group and CONSORT. The group targets methodological areas relevant to disciplines represented at institutions like Imperial College London, Karolinska Institutet, University of Sydney, Peking University, and University of Cape Town and liaises with specialty societies including American College of Physicians, European Society of Cardiology, International Society for Pharmacoeconomics and Outcomes Research, and Society for Clinical Trials.

Methodological contributions

Contributions span statistical techniques, bias assessment, and evidence synthesis methods referenced by journals including The BMJ, The Lancet, JAMA, and Annals of Internal Medicine. Work covers meta-analysis models used in landmark studies tied to researchers at Cochrane Collaboration, Oxford University Centre for Evidence-based Medicine, McMaster Evidence Review Group, and Nuffield Department of Population Health. The group has advanced approaches to handling heterogeneity and network synthesis used by teams at University College London, Stanford University, Massachusetts General Hospital, and Yale University. It has produced guidance that informs regulatory agencies such as Food and Drug Administration, European Medicines Agency, and reimbursement decisions at Centers for Medicare & Medicaid Services and national ministries represented by Ministry of Health (United Kingdom), Ministry of Health (Brazil), and Ministry of Health (India).

Organization and governance

Governance involves an international convenor and steering committee drawing members from universities and organizations including University of Bristol, University of Edinburgh, Duke University, University of Washington, National University of Singapore, King's College London, and Monash University. It interacts with umbrella organizations like Cochrane Collaboration, Campbell Collaboration, Equator Network, and international consortia such as Global Evidence Synthesis Initiative. Funding and oversight partners have included Wellcome Trust, National Institutes of Health, European Commission Horizon 2020, Gates Foundation, and national research councils like Medical Research Council (UK) and Australian Research Council.

Collaborations and impact

Collaborations extend to guideline developers such as National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, World Health Organization, and specialty guideline groups including American Heart Association, American Diabetes Association, and European Respiratory Society. The group's methodological outputs influence systematic reviews cited in policy documents from World Health Organization, United Nations, European Commission, and national health departments. Partnerships with publishers like Wiley-Blackwell, BMJ Publishing Group, and Elsevier have disseminated methods through journals and textbooks authored by scholars at Harvard School of Public Health, London School of Hygiene & Tropical Medicine, Columbia University, and Johns Hopkins Bloomberg School of Public Health.

Training and capacity building

Training initiatives involve workshops, online courses, and mentorship programs run jointly with institutions such as London School of Hygiene & Tropical Medicine, University of Oxford, McMaster University, Karolinska Institutet, Zhejiang University, and networks like Global Evidence Synthesis Initiative and Evidence Synthesis Ireland. Courses are offered through platforms associated with Coursera, edX, and university continuing education departments; they attract participants from hospitals like Mayo Clinic, Cleveland Clinic, and ministries including Ministry of Health (South Africa). Scholarship and fellowship schemes have been supported by funders including Wellcome Trust, Gates Foundation, and national research councils.

Challenges and future directions

Ongoing challenges include integrating methods across diverse fields represented at World Health Organization, European Medicines Agency, Food and Drug Administration, and academic hubs such as University of Cambridge, Princeton University, Tsinghua University, and University of Melbourne; addressing reproducibility debates prominent in venues like National Academies of Sciences, Engineering, and Medicine; and responding to innovations from data science groups at Google DeepMind, Microsoft Research, IBM Research, and computational centers like ETH Zurich and Max Planck Society. Future directions emphasize harmonization with reporting standards from PRISMA Statement, improvements in bias assessment used by GRADE Working Group, expansion of training with partners such as WHO Academy, and enhanced collaboration with policy-makers at Organisation for Economic Co-operation and Development, United Nations, and regional health bodies.

Category:Evidence-based medicine